PeptideStack
5.2kquestions
20kanswers
220users

How do I interpret a lipase trend across three draws?

Asked 2 Jan 2025Modified 15 months agoViewed 19k times
20

The clinician who ordered the panel was not concerned; I would still like to understand it.

I would like help reading this properly rather than being told what conclusion to reach.

I have the full report including the method section, so I can quote specifics if that helps.

What would I need in addition before this supported a decision?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
shareeditfollowflag
RS
askedrota_site36k272 Jan 2025
6Worth adding the time of day, since a couple of these have a diurnal swing. – sinead_gaffney 8 months ago
5Voting to keep this open — it is more specific than it first looks. – ines_brandt 6 months ago
add a comment

4 Answers

Accepted answer first, then by votes
59

Accepted answer

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Worth being precise here: haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
FB
answered · acceptedfresh_bac9.7k1627 Apr 2025
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
63

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
DW
answereddeamidation_watch45k584 Apr 2025
41

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Research-use compounds are not approved for human use, and no panel makes that safer.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
DS
answeredDr_Ravi_Selvarajah35k13715 Apr 2025
27

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

edited 15 Jan 2025 by lipid_panel_q — reworded for clarity after a comment

shareimprove this answerflag
LQ
answeredlipid_panel_q36k1278 Jan 2025
4Adding a vote because this deserves more of them. – marta_okonkwo 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.